CRG Experience and History

Our Mission

Chesapeake Research Group, LLC is a clinical study investigative site dedicated to supporting our clients in the development of products by conducting rigorous and efficient clinical drug/ device trials.

Our staff is committed to producing and submitting clean and precise data in a timely fashion. We are a multi-specialty site that has established affiliations with primary care and other specialty groups.

Our History

Dr. Gottlieb was a researcher/investigator working as a consultant for a research group. At the same time, Deborah Tunick worked as a nurse at the same site. When the site closed its doors, Dr. Gottlieb and Deborah joined together and opened Chesapeake Research Group.

Our Experience

We have conducted the following:

    • A Randomized, Double-Blind, Placebo-Controlled Parallel Group Phase III Study of the Efficacy, Tolerability, and Safety of (the study drug) in the Treatment of Pain Associated with Grade 1 or Grade 2 Ankle Sprain or Strain.

 

    • A Phase III Open-Label, Single Arm Study to Assess the Safety of (the study drug) for Minimal-to-Moderate Sedation in Patients Undergoing Minor Surgical Procedures.

 

    • A Phase III, Open-Label Period Followed by Randomized, Double-Blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of (the study drug) Compared to Placebo in Subjects with Chronic Low Back Pain.

 

    • A Phase III, Randomized, Multicenter, Double-Blind Study Comparing the Analgesic Efficacy of (the study drug) to Placebo in Subjects with Osteoarthritis.

 

    • A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Two Week Study to Assess the Safety and Efficacy of (the study drug) in Subjects with Pain from Moderate Lateral Epicondylitis.

 

    • A Randomized, Double-Blind, Placebo-Controlled, Multi-center Phase III Study to Evaluate the Long-Term Safety of (the study drug) for 12 Months for the treatment of Opioid-Induced Bowel Dysfunction in Adults taking Opioid Therapy for Persistent Non-Cancer Pain.

 

    • An Open Label Safety Study with Intermittent Use of (the study drug) in Subjects with Lower Back Pain, Pain from Osteoarthritis of the Knee, Shoulder Pain, or Lateral Epicondylitis Pain.

 

    • An Open Label Study Evaluating the Safety and Tolerability of Long Term Administration of (the study drug) in Subjects with Moderate to Severe Chronic Non-Malignant Pain.

 

    • A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of (the study drug) versus Midazolam HCl for Sedation in Patients Undergoing Minor Surgical Procedures.

 

    • A Randomized, Multi-Center, Double-Blind Study Comparing the Analgesic Efficacy of (the study drug) Extended Release and Placebo in Subjects with Osteoarthritis.

 

    • A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Trial of (the study drug) in Subjects Undergoing Bunionectomy with First Metatarsal Osteotomy Surgery.

 

    • A Randomized, Double-Blind, Placebo-controlled Study Comparing the Analgesic Activity of (the study drug) Extended Release and Placebo in Subjects with Pain Following Bunionectomy Surgery.

 

    • A Multi-Center, Single Dose, Double-blind, Placebo-Controlled, Randomized, Pilot Study To Investigate the Assay Sensitivity of Single Digit Hammertoe Surgery As A Model For The Study Of Analgesic Drugs In Acute Pain.

 

    • A Randomized Multiple Dose Assessment of the Safety of the (the study drug) Ready to Use (RTU) Formulation Compared to Parecoxib Sodium Lyophilized Preparation in Patients in Pain Following a Bunionectomy.

 

    • A Randomized, Double-Blind, Placebo Controlled, Multiple Dose Assessment of the Analgesic Efficacy of the Dosing Regimen of (the study drug) Compared to Placebo Patients in Pain Following a Bunionectomy.

 

    • A Multiple Dose Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of (the study drug) Compared to Placebo in Patients for Treatment of Post-Surgical Pain from Bunionectomy Surgery.

 

    • A Randomized, Double-Blind, Parallel-Group Study Assessing the Analgesic Efficacy and Safety of Four Dose Levels of (the study drug) compared to Ibuprofen 400 mg, Morphine 60 mg and Placebo in Patients with acute Pain Following Orthopedic Surgery (Bunionectomy).

 

    • A randomized double-blind, Placebo and active comparator controlled parallel group multi-center study of (the study drug) and naprelan in the treatment of post-Bunionectomy surgery pain.

 

    • A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study Assessing the Analgesic Efficacy and Safety of Five Dose Levels of (the study drug) compared to Morphine 60mg, Ibuprofen 400 mg,and Placebo in patients following Orthopedic Surgery (Bunionectomy).

 

    • Analgesic Efficacy of Single doses of (the study drug) and Multiple Doses of (the study drug) Compared with Single and Multiple doses of Naproxen Sodium 500mg or placebo in Patients with Pain from Outpatient Orthopedic surgery (Bunionectomy).

 

    • Comparative Analgesic Efficacy of Single and Multiple Doses of (the study drug), Naproxen Sodium 550mg, or Placebo in Pain Following Outpatient Orthopedic surgery (Bunionectomy)

 

    • A Double Blind Placebo and Active-Controlled Comparison of the Analgesic Activity of (the study drug) and Placebo in Post Bunionectomy Surgical Patients.

Testimonials

“The Chesapeake Research Group, headed by Dr. Ira Gottlieb, is a highly experienced facility for clinical trial research. We have worked with Dr. Gottlieb and his team on multiple trials and in multiple phases of development. They specialize in research related to the treatment of acute pain, especially postoperative pain using surgical models. Refreshingly, they do what they say they can do and deliver clean data in a timely fashion. They have a deep understanding of what it takes to comply with all of the regulatory requirements. Their commitment is also reflected in the excellent care of the patients.”

James Campbell, M.D., President and Chief Scientific Officer of Centrexion Therapeutics and Professor Emeritus of neurosurgery at Johns Hopkins University School of Medicine


“We have always found Chesapeake Research Group to be an extremely professional and thorough clinical research site that delivers accurate and timely information. They have played an important role in our studies and remain at the top of our list for Baltimore – Washington, D.C. area sites.”

-Gabrielle Poirier, Clinical Project Manager


“It was a privilege to work with Chesapeake Research Group. The site enrolled quickly, the protocol was followed without deviations, data was high quality, and the site promptly responded to any sponsor request. Site staff was experienced in clinical research, provided optimal care of study patients, and adhered to all regulations while always being pleasant.”

-Rosemary Keller PhD CRNP, Senior Clinical Scientist, Recro Pharma